Insulin therapy in maturity-onset diabetes (Q37723462)

22 August 2017

1 reference

title

Insulin therapy in maturity-onset diabetes (English)

1 reference

22 August 2017

1 reference

Sane T

1 reference

22 August 2017

Mustajoki P

series ordinal

1 reference

22 August 2017

Välimäki M

series ordinal

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 February 1991

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

page(s)

13-19

1 reference

Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Type 2 (non-insulin-dependent) diabetes--an epidemiological overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

When to use insulin in the maturity onset diabetic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Insulin treatment of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Role of insulin resistance in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Effect of fatty acids on glucose production and utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

One month's insulin treatment of type II diabetes: the early and medium-term effects following insulin withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Treatment of patients with non-insulin-dependent diabetes mellitus: diabetic control and insulin secretion and action after different treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

C-Peptide Levels as a Criterion in Treatment of Maturity-Onset Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

[Effectiveness of combined treatment with glibenclamide and insulin in secondary sulfonylurea failure. A controlled multicenter double-blind clinical trial]

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

New tactics for type 2 diabetes: regimens based on intermediate-acting insulin taken at bedtime.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Infection and diabetes: the case for glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

A community study of high density lipoproteins in adult noninsulin-dependent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Effect of insulin therapy on lipoproteins in non-insulin dependent diabetes mellitus (NIDDM).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Changes in High Density Lipoprotein Cholesterol after Initiation of Insulin Therapy in Non-Insulin Dependent Diabetes Mellitus: Relationship to Changes in Body Weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Reversal of severe diabetic hyperlipidemia by prandial insulinization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Insulin Dependence: Problems with the Classification of 100 Consecutive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109147924

10.3109/07853899109147924

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference